Su Cheong Yeom

924 total citations · 1 hit paper
33 papers, 669 citations indexed

About

Su Cheong Yeom is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Su Cheong Yeom has authored 33 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Oncology. Recurrent topics in Su Cheong Yeom's work include CRISPR and Genetic Engineering (10 papers), Virus-based gene therapy research (5 papers) and RNA Interference and Gene Delivery (5 papers). Su Cheong Yeom is often cited by papers focused on CRISPR and Genetic Engineering (10 papers), Virus-based gene therapy research (5 papers) and RNA Interference and Gene Delivery (5 papers). Su Cheong Yeom collaborates with scholars based in South Korea, Puerto Rico and United States. Su Cheong Yeom's co-authors include Ki Taek Nam, Xingshu Li, Gyoungmi Kim, Yoonji Lee, Nahyun Kwon, Yejin Cho, Sungsook Yu, Juyoung Yoon, Dayoung Lee and Jian‐Dong Huang and has published in prestigious journals such as Journal of the American Chemical Society, Nano Letters and PLoS ONE.

In The Last Decade

Su Cheong Yeom

32 papers receiving 666 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy

2022 130 citations M. Kim, Michaela Jeong et al. Science Advances profile →

Peers

Countries citing papers authored by Su Cheong Yeom

Since Specialization

Citations

This map shows the geographic impact of Su Cheong Yeom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Cheong Yeom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Cheong Yeom more than expected).

Fields of papers citing papers by Su Cheong Yeom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Cheong Yeom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Cheong Yeom. The network helps show where Su Cheong Yeom may publish in the future.

Co-authorship network of co-authors of Su Cheong Yeom

This figure shows the co-authorship network connecting the top 25 collaborators of Su Cheong Yeom. A scholar is included among the top collaborators of Su Cheong Yeom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Cheong Yeom. Su Cheong Yeom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Estradiol rescues male hydroxyl radical-mediated Charcot-Marie-Tooth 2Z by Morc2a stabilization through autophagy inhibition in a murine model 2025 ·Acta Neuropathologica ·(unknown), Soo Hyun Nam, (unknown), (unknown), (unknown), (unknown), Jae‐Hyung Jang, Byung‐Ok Choi, Su Cheong Yeom	0
2	Polyphenol-Enabled 2D Nanopatch for Enhanced Nasal Mucoadhesion and Immune Activation 2024 ·Nano Letters ·(unknown), (unknown), (unknown), Haeshin Lee, Su Cheong Yeom	3
3	Morc2a variants cause hydroxyl radical-mediated neuropathy and are rescued by restoring GHKL ATPase 2024 ·Brain ·(unknown), (unknown), Soo Hyun Nam, (unknown), (unknown), (unknown), Gap‐Don Kim, Choonkyun Jung, Do Young Hyeon, Daehee Hwang, Byung‐Ok Choi, Su Cheong Yeom	3
4	In vivo genome editing for hemophilia B therapy by the combination of rebalancing and therapeutic gene knockin using a viral and non-viral vector 2023 ·Molecular Therapy — Nucleic Acids ·Jeong Hyeon Lee, (unknown), Dong Woo Song, (unknown), (unknown), Minjeong Kim, Yeji Lee, Seokjoong Kim, Hyukjin Lee, Su Cheong Yeom	26
5	In vivo genome editing using 244-cis LNPs and low-dose AAV achieves therapeutic threshold in hemophilia A mice 2023 ·Molecular Therapy — Nucleic Acids ·(unknown), Yeji Lee, (unknown), (unknown), (unknown), (unknown), Myeongjin Choi, Kyoung‐Sik Moon, Haeshin Lee, Hyukjin Lee, Su Cheong Yeom	13
6	Improved natural food colorant production in the filamentous fungus Monascus ruber using CRISPR-based engineering 2023 ·Food Research International ·(unknown), Suk Jung Han, Seung Chul Shin, Su Cheong Yeom, Hyo Jin Kim	15
7	Comparison of the Seven Interleukin-32 Isoforms’ Biological Activities: IL-32θ Possesses the Most Dominant Biological Activity 2022 ·Frontiers in Immunology ·(unknown), Siyoung Lee, (unknown), Sinae Kim, Tam Thanh Nguyen, (unknown), (unknown), Hyunjhung Jhun, Ho‐Young Park, Young-Min Lee, Su Cheong Yeom, Sang‐Yeob Kim, Yong‐Gil Kim, Soohyun Kim	9
8	In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy breakdown → 2022 ·Science Advances ·(unknown), M. Kim, (unknown), (unknown), (unknown), Michaela Jeong, Yeji Lee, (unknown), (unknown), (unknown), Hye-Rim Lee, Kyu Jun Lee, (unknown), Jae Young Lee, Seokjoong Kim, Jun Chang, Hyukjin Lee, Dong Woo Song, Su Cheong Yeom	130
9	A Paradoxical Effect of Interleukin-32 Isoforms on Cancer 2022 ·Frontiers in Immunology ·(unknown), Siyoung Lee, (unknown), Sinae Kim, Tam Thanh Nguyen, (unknown), (unknown), Hyunjhung Jhun, Ho‐Young Park, Young-Min Lee, Su Cheong Yeom, (unknown), (unknown), Yong‐Gil Kim, Soohyun Kim	13
10	Genome editing-mediated knock-in of therapeutic genes ameliorates the disease phenotype in a model of hemophilia 2022 ·Molecular Therapy — Nucleic Acids ·Jeong Hyeon Lee, (unknown), (unknown), (unknown), Kyu Jun Lee, (unknown), (unknown), Hye-Rim Lee, (unknown), (unknown), (unknown), Seokjoong Kim, Su Cheong Yeom, Dong Woo Song	12
11	In vivo multiplex gene targeting with Streptococcus pyogens and Campylobacter jejuni Cas9 for pancreatic cancer modeling in wild-type animal 2020 ·Journal of Veterinary Science ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ok Jae Koo, (unknown), Yang‐Kyu Choi, Su Cheong Yeom	9
12	The position of the target site for engineered nucleases improves the aberrant mRNA clearance in in vivo genome editing 2020 ·Scientific Reports ·(unknown), Sungsook Yu, (unknown), (unknown), Young Jin, (unknown), Ji-Young Cha, Yoon Ki Kim, Su Cheong Yeom, Ki Taek Nam, Han‐Woong Lee	2
13	Efficient and specific generation of knockout mice using Campylobacter jejuni CRISPR/Cas9 system 2020 ·Biochemistry and Biophysics Reports ·Jae Young Lee, (unknown), Ji Hyun Bae, (unknown), (unknown), Seokjoong Kim, Sin‐Gi Park, Ok Jae Koo, Su Cheong Yeom	6
14	8-OxoG in GC-rich Sp1 binding sites enhances gene transcription in adipose tissue of juvenile mice 2019 ·Scientific Reports ·Jong Woo Park, (unknown), Sung Woo Kim, Tae Min Kim, Su Cheong Yeom, Jaeku Kang, Joonghoon Park	15
15	Multiple sgRNAs with overlapping sequences enhance CRISPR/Cas9-mediated knock-in efficiency 2018 ·Experimental & Molecular Medicine ·(unknown), Jae Young Lee, (unknown), Ok Jae Koo, (unknown), Min Hee Jung, Ji Hyun Bae, (unknown), (unknown), (unknown), (unknown), Su Cheong Yeom	41
16	Neuronal Nitric Oxide Synthase Is a Novel Biomarker for the Interstitial Cells of Cajal in Stress-Induced Diarrhea-Dominant Irritable Bowel Syndrome 2018 ·Digestive Diseases and Sciences ·(unknown), Ji Hyun Bae, (unknown), (unknown), Ki Taek Nam, Il Yong Kim, Je Kyung Seong, Yong Chan Lee, Su Cheong Yeom	14
17	The accessory proteins REEP5 and REEP6 refine CXCR1-mediated cellular responses and lung cancer progression 2016 ·Scientific Reports ·Cho Rong Park, (unknown), Sumi Park, (unknown), (unknown), Su Cheong Yeom, (unknown), Curie Ahn, Sang‐Heon Lee, Jae Young Seong, Jong‐Ik Hwang	19
18	Availability of Empty Zona Pellucida for Generating Embryonic Chimeras 2015 ·PLoS ONE ·Chi‐Hun Park, (unknown), (unknown), Jae Yeon Hwang, Kyungjun Uh, Su Cheong Yeom, Curie Ahn, (unknown)	6
19	Pregnancy in postpartum estrus induces inflammatory milk production and catagen specific pup skin inflammation in interleukin-10 deficient mice 2013 ·Journal of Dermatological Science ·(unknown), (unknown), (unknown), Byeong-Cheol Kang, (unknown), (unknown), Dong‐Sup Lee, Su Cheong Yeom	4
20	Action of Lipopolysaccharide on Interstitial Cells of Cajal from Mouse Small Intestine 2012 ·Pharmacology ·(unknown), Seok Choi, Pawan K. Shahi, (unknown), Chan Guk Park, Young Dae Kim, Jun Lee, (unknown), (unknown), Su Cheong Yeom, (unknown), Seung‐Yong Seong, Insuk So, Jae Yeoul Jun	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact